These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24866986)

  • 1. Statins in the elderly: an answered question?
    Zoungas S; Curtis A; Tonkin A; McNeil J
    Curr Opin Cardiol; 2014 Jul; 29(4):372-80. PubMed ID: 24866986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benefits and risks for primary prevention with statins in the elderly].
    Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F
    Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the elderly: recent evidence and current indications.
    Schiattarella GG; Perrino C; Magliulo F; Ilardi F; Serino F; Trimarco V; Izzo R; Amato B; Terranova C; Cardin F; Militello C; Leosco D; Trimarco B; Esposito G
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):47-55. PubMed ID: 23160507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
    Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for the primary prevention of cardiovascular disease in the elderly.
    Lowe RN; Vande Griend JP; Saseen JJ
    Consult Pharm; 2015 Jan; 30(1):20-30. PubMed ID: 25591028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy for primary prevention of cardiovascular disease.
    Taylor FC; Huffman M; Ebrahim S
    JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.
    Mills EJ; Wu P; Chong G; Ghement I; Singh S; Akl EA; Eyawo O; Guyatt G; Berwanger O; Briel M
    QJM; 2011 Feb; 104(2):109-24. PubMed ID: 20934984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
    Chen YH; Feng B; Chen ZW
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating statins in the elderly: the evolving challenge.
    Walker DB; Jacobson TA
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):182-7. PubMed ID: 18316955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 14. [Does statin therapy reduce the risk of stroke? A meta-analysis].
    Sirol M; Bouzamondo A; Sanchez P; Lechat P
    Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
    Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
    Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Prescribing in the Elderly: Special Considerations.
    Leya M; Stone NJ
    Curr Atheroscler Rep; 2017 Oct; 19(11):47. PubMed ID: 29019063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
    Chodick G; Shalev V
    Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin therapy in the elderly: observational and randomized controlled trials support event reduction.
    Lewis SJ
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):10-6. PubMed ID: 15133424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.